C102H98Cl2F2N32O16S — CID 158076596
5-chloro-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;N-[5-(6-chloro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-methoxy-5-sulfamoylbenzamide;1-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylurea;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(piperidin-1-ylmethyl)furan-2-carboxamide (PubChem CID 158076596) has the molecular formula C102H98Cl2F2N32O16S and a molecular weight of 2169.08 g/mol. Its IUPAC name is 5-chloro-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;N-[5-(6-chloro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-methoxy-5-sulfamoylbenzamide;1-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylurea;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(piperidin-1-ylmethyl)furan-2-carboxamide.
| Compound Name | 5-chloro-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;N-[5-(6-chloro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-methoxy-5-sulfamoylbenzamide;1-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylurea;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(piperidin-1-ylmethyl)furan-2-carboxamide |
|---|---|
| PubChem CID | 158076596 |
| Molecular Formula | C102H98Cl2F2N32O16S |
| Molecular Weight | 2169.08 g/mol |
| Exact Mass | 2166.69 |
| IUPAC Name | 5-chloro-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;N-[5-(6-chloro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2-methoxy-5-sulfamoylbenzamide;1-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylurea;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(piperidin-1-ylmethyl)furan-2-carboxamide |
| SMILES | COc1cc2nc(-c3[nH]ncc3NC(=O)c3cc(Cl)c[nH]c3=O)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)c3cc(S(N)(=O)=O)ccc3OC)[nH]c2cc1OC.O=C(Nc1ccccc1)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2cc(Cl)ncc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(CN2CCCCC2)o1 |
| InChI | InChI=1S/C26H31N7O3.C22H23N7O2.C20H20N6O6S.C18H15ClN6O4.C16H9ClF2N6O/c34-26(23-7-5-19(36-23)17-32-8-2-1-3-9-32)30-22-15-27-31-24(22)25-28-20-6-4-18(14-21(20)29-25)16-33-10-12-35-13-11-33;30-22(24-16-4-2-1-3-5-16)27-19-13-23-28-20(19)21-25-17-7-6-15(12-18(17)26-21)14-29-8-10-31-11-9-29;1-30-15-5-4-10(33(21,28)29)6-11(15)20(27)25-14-9-22-26-18(14)19-23-12-7-16(31-2)17(32-3)8-13(12)24-19;1-28-13-4-10-11(5-14(13)29-2)23-16(22-10)15-12(7-21-25-15)24-18(27)9-3-8(19)6-20-17(9)26;17-12-4-9-10(5-20-12)23-15(22-9)14-11(6-21-25-14)24-16(26)13-7(18)2-1-3-8(13)19/h4-7,14-15H,1-3,8-13,16-17H2,(H,27,31)(H,28,29)(H,30,34);1-7,12-13H,8-11,14H2,(H,23,28)(H,25,26)(H2,24,27,30);4-9H,1-3H3,(H,22,26)(H,23,24)(H,25,27)(H2,21,28,29);3-7H,1-2H3,(H,20,26)(H,21,25)(H,22,23)(H,24,27);1-6H,(H,21,25)(H,22,23)(H,24,26) |
| InChIKey | FMLHIICSVCLQHO-UHFFFAOYSA-N |
| XLogP | 15.02 |
| TPSA | 637.71 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 155 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2169.08 |
| LogP ≤ 5 | 15.02 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 30 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|